Copanlisib dihydrochloride

小分子

库潘尼西盐酸

Copanlisib hydrochloride (USAN) | COPANLISIB HYDROCHLORIDE [MI] | COPANLISIB HCI | UNII-03ZI7RZ52O | Q27291473 | BAY 80-6946 dihydrochlorideBAY 80-6946 dihydrochloride | COPANLISIB HYDROCHLORIDE [WHO-DD] | KS-1048 | 03ZI7RZ52O

Copanlisib dihydrochloride

C651590-5mg

5mg

Moligand™

≥99%

-20°C储存,干燥

超低温冰袋运输

对湿度敏感

Copanlisib dihydrochloride (BAY 80-6946 dihydrochloride) 是一种有效的，选择性的和 ATP 竞争性的泛 I 类 PI3K 抑制剂，对 PI3Kα，PI3Kδ，PI3Kβ 和 PI3Kγ 的 IC50 分别为 0.5 nM、0.7 nM、3.7 nM 和 6.4 nM。除 mTOR 外，Copanlisib dihydrochloride 对其他脂质和蛋白激酶的选择性超过 2000 倍。Copanlisib dihydrochloride 具有优异的抗肿瘤活性。 Copanlisib dihydrochloride (BAY 80-6946 dihydrochloride) is a potent, selective and ATP-competitive pan-class I PI3K inhibitor, with IC50s of 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ, respectively. Copanlisib dihydrochloride has more than 2,000-fold selectivity against other lipid and protein kinases, except for mTOR. Copanlisib dihydrochloride has superior antitumor activity .

Copanlisib dihydrochloride（BAY 80-6946 dihydrochloride）是一种强效、选择性和 ATP 竞争性泛 I 类 PI3K 抑制剂，对 PI3Kα 、PI3Kδ 、PI3Kβ 和 PI3Kγ 的 IC 50 s 分别为 0.5 nM、0.7 nM、3.7 nM 和 6.4 nM。

1402152-13-9

C23H30Cl2N8O4

553.44 g/mol

815-039-6

135565785

COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5.Cl.Cl

2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]pyrimidine-5-carboxamide;dihydrochloride

1S/C23H28N8O4.2ClH/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15;;/h3-4,13-14,25H,2,5-12H2,1H3,(H2,24,26,27);2*1H

KWVVOPDWPMORCQ-UHFFFAOYSA-N

COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5.Cl.Cl

1402152-13-9；1032568-63-0

H2O : 20 mg/mL (36.14 mM; Need ultrasonic) DMSO : 5 mg/mL (9.03 mM; ultrasonic and warming and heat to 60°C)

4

9

7

552.177 Da

552.177 Da

140.000 Ų

37

0

974

0

3